McKesson (NYSE:MCK) Issues FY 2027 Earnings Guidance

McKesson (NYSE:MCK) issued an update on its FY 2027 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 44.200-45.000 for the period, compared to the consensus estimate of 44.650. The company issued revenue guidance of -.

Analysts Set New Price Targets

MCK has been the subject of a number of analyst reports. Barclays increased their price objective on McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. TD Cowen upped their price objective on shares of McKesson from $989.00 to $1,006.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Robert W. Baird set a $1,015.00 target price on McKesson in a research note on Thursday, August 6th. Wells Fargo & Company boosted their price target on McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a report on Tuesday, August 11th. Finally, UBS Group upped their price target on McKesson from $1,050.00 to $1,080.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $973.44.

McKesson Trading Down 1.0%

Shares of MCK opened at $856.46 on Thursday. McKesson has a 1-year low of $723.68 and a 1-year high of $999.00. The firm’s 50-day moving average price is $877.23 and its 200-day moving average price is $833.40. The firm has a market capitalization of $99.86 billion, a price-to-earnings ratio of 22.92, a PEG ratio of 1.72 and a beta of 0.30.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. During the same period in the prior year, the firm earned $8.26 earnings per share. McKesson’s revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, research analysts forecast that McKesson will post 44.64 EPS for the current fiscal year.

McKesson Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This is a boost from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Tuesday, September 1st. McKesson’s dividend payout ratio is presently 10.06%.

Insiders Place Their Bets

In other McKesson news, CAO B Jr sold 111 shares of the stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the transaction, the chief accounting officer owned 521 shares in the company, valued at approximately $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley Lerman sold 301 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 8,875 shares of company stock worth $7,083,441. 0.06% of the stock is owned by corporate insiders.

About McKesson

McKesson Corporation (NYSE:MCK) is a healthcare services and information technology company that distributes pharmaceuticals, specialty drugs, medical supplies and other healthcare products. The company serves pharmacies, hospitals, health systems, physician practices, biopharma manufacturers and other healthcare providers, helping move products from manufacturers to patients and care settings.

McKesson’s principal operations include pharmaceutical distribution, medical-surgical supply distribution and technology-enabled services for pharmacies and providers.